Latest filing published 22 Nov 2022 for Theravance Biopharma, Inc., €262k.
Filing timeline
BuySaleInsider track record
Andrew A. Hindman: trading record in brief
This profile gathers the share dealings of Andrew A. Hindman across 2 companies, led by Acorda Therapeutics Inc and Theravance Biopharma, Inc. The record holds 38 filings, for trades running from 13 May 2014 to 20 November 2022.
No open-market purchase appears, only 10 sales worth €2.0M. Outside the open market, there are 28 share grants. 2022 to date brings no purchases and 1 sale.
On 22 November 2022 came the latest disclosure, a share grant for €262k in Theravance Biopharma, Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Andrew A. Hindman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 25,057 shares@ US$10.8513.3% of flowOrdinary SharesSEC:0001415889-22-011671:1
- 65,000 shares@ US$11.019149.0% of flowOrdinary SharesSEC:0001415889-22-011671:0
- 25,676 shares@ US$9.3416.9% of flowOrdinary SharesSEC:0001415889-22-008983:0
- 20,000 shares0Ordinary SharesSEC:0001415889-22-008006:0
- 3,365 shares@ US$8.742.0% of flowOrdinary SharesSEC:0001415889-22-005631:0
- 25,973 shares@ US$9.6115.6% of flowOrdinary SharesSEC:0001415889-22-001699:0
- 340,000 shares0Ordinary SharesSEC:0001179110-21-010638:0
- 1,350 shares@ US$8.360.7% of flowOrdinary SharesSEC:0001415889-21-005466:0
- 17,464 shares@ US$14.0514.9% of flowOrdinary SharesSEC:0001179110-21-008394:0
- 942 shares@ US$17.801.0% of flowOrdinary SharesSEC:0001179110-21-005842:0
- 3,984 shares@ US$18.793.6% of flowOrdinary SharesSEC:0001179110-21-002160:0
- 65,000 shares0Ordinary SharesSEC:0001179110-21-001536:0
- 4,323 shares@ US$18.224.0% of flowOrdinary SharesSEC:0001179110-20-009265:0
- 20,000 shares0Ordinary SharesSEC:0001179110-20-008540:0
- 7,060 shares@ US$25.9010.3% of flowOrdinary SharesSEC:0001179110-20-002146:0
- 43,550 shares0Ordinary SharesSEC:0001179110-20-001200:0
- 20,000 shares0Ordinary SharesSEC:0001179110-20-001200:1
- 50,000 shares0Ordinary SharesSEC:0001179110-19-008497:0
- 9,045 shares0Common StockSEC:0001209191-19-018791:0
- 877 shares@ US$13.381.0% of flowCommon StockSEC:0001209191-19-012966:0
- 2,300 shares0Common StockSEC:0001209191-18-064141:0
- 753 shares@ US$20.561.4% of flowCommon StockSEC:0001209191-18-061104:0
- 879 shares@ US$20.281.6% of flowCommon StockSEC:0001209191-18-057552:0
- 2,300 shares0Common StockSEC:0001209191-18-050629:0
- 42,615 shares@ US$24.2670.8% of flowCommon StockSEC:0001209191-18-034062:0
25 of 38 declarations
